Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 Mutations
Clinical trial NCT07025018 · RECRUITING
Trial details
- NCT number
- NCT07025018
- Sponsor
- Hutchmed
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-15
- Primary completion
- 2026-12-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.